Lenvima (4 Mg Daily Dose) Coupons & Savings Card – Discount Prices from $25924.35

When taking Lenvima at a daily dose of 4 mg, it's important to be aware of several potential risks:

Hypertension (High Blood Pressure): Lenvima can cause an increase in blood pressure. Regular monitoring is essential, and any significant rise should be reported to your healthcare provider.

Cardiac Dysfunction: There is a risk of heart-related issues, including heart failure. Be vigilant for symptoms such as chest pain, shortness of breath, or swelling in the legs, and seek medical attention if they occur.

Arterial Thromboembolic Events: Lenvima may increase the risk of blood clots leading to heart attacks or strokes. Immediate medical care is necessary if you experience sudden chest pain, difficulty speaking, or weakness on one side of the body.

Hepatotoxicity (Liver Damage): Liver problems, including liver failure, have been reported. Regular liver function tests are recommended, and any signs like yellowing of the skin or eyes should be promptly addressed.

Renal Impairment (Kidney Problems): Kidney issues, including failure, can occur. Monitoring kidney function through regular tests is advised.

Proteinuria (Protein in Urine): The presence of protein in urine is a possible risk. Routine urine tests can help detect this condition early.

Gastrointestinal Perforation and Fistula Formation: Lenvima may lead to serious gastrointestinal issues, such as holes or abnormal connections in the digestive tract. Severe abdominal pain should be reported immediately.

QT Interval Prolongation: This medication can affect heart rhythm. Regular heart monitoring is important, especially if you have a history of heart rhythm problems.

Hypocalcemia (Low Calcium Levels): Low calcium levels can occur. Regular blood tests to monitor calcium are recommended, and supplementation may be necessary.

Reversible Posterior Leukoencephalopathy Syndrome (RPLS): A rare brain condition has been associated with Lenvima. Symptoms like severe headaches, vision changes, or seizures require immediate medical attention.

Hemorrhagic Events (Bleeding): Serious bleeding events have been reported. Any unusual bleeding or bruising should be promptly discussed with your healthcare provider.

Thyroid Dysfunction: Lenvima can affect thyroid function, potentially leading to hypothyroidism. Regular thyroid function tests are advised.

Impaired Wound Healing: The medication may slow down the healing process. Inform your healthcare provider about any planned surgeries.

Osteonecrosis of the Jaw (ONJ): A condition affecting the jawbone has been reported. Maintaining good oral hygiene and regular dental check-ups are important.

Embryo-Fetal Toxicity: Lenvima can harm an unborn baby. Effective contraception is necessary during treatment and for at least 30 days after the last dose.

Regular monitoring and open communication with your healthcare provider are crucial to manage these risks effectively.